285 related articles for article (PubMed ID: 36943819)
1. Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case-control study and meta-analysis.
Fitzpatrick D; Pirie K; Reeves G; Green J; Beral V
PLoS Med; 2023 Mar; 20(3):e1004188. PubMed ID: 36943819
[TBL] [Abstract][Full Text] [Related]
2. Steroidal contraceptives and bone fractures in women: evidence from observational studies.
Lopez LM; Chen M; Mullins Long S; Curtis KM; Helmerhorst FM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009849. PubMed ID: 26195091
[TBL] [Abstract][Full Text] [Related]
3. Steroidal contraceptives and bone fractures in women: evidence from observational studies.
Lopez LM; Chen M; Mullins S; Curtis KM; Helmerhorst FM
Cochrane Database Syst Rev; 2012 Aug; (8):CD009849. PubMed ID: 22895991
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptives and breast cancer risk among younger women.
Brinton LA; Daling JR; Liff JM; Schoenberg JB; Malone KE; Stanford JL; Coates RJ; Gammon MD; Hanson L; Hoover RN
J Natl Cancer Inst; 1995 Jun; 87(11):827-35. PubMed ID: 7791232
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer among young U.S. women in relation to oral contraceptive use.
White E; Malone KE; Weiss NS; Daling JR
J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
[TBL] [Abstract][Full Text] [Related]
6. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer.
Contraception; 1996 Sep; 54(3 Suppl):1S-106S. PubMed ID: 8899264
[TBL] [Abstract][Full Text] [Related]
8. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
Collaborative Group on Hormonal Factors in Breast Cancer
Lancet; 2019 Sep; 394(10204):1159-1168. PubMed ID: 31474332
[TBL] [Abstract][Full Text] [Related]
9. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
van Leeuwen FE
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies.
Collaborative Group on Hormonal Factors in Breast Cancer
Lancet; 1996 Jun; 347(9017):1713-27. PubMed ID: 8656904
[TBL] [Abstract][Full Text] [Related]
11. Exogenous progestins and breast cancer.
Stanford JL; Thomas DB
Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
[TBL] [Abstract][Full Text] [Related]
12. Oral contraceptives and breast cancer.
Brinton LA; Hoover R; Szklo M; Fraumeni JF
Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Hormonal contraceptive use and risk of glioma among younger women: a nationwide case-control study.
Andersen L; Friis S; Hallas J; Ravn P; Kristensen BW; Gaist D
Br J Clin Pharmacol; 2015 Apr; 79(4):677-84. PubMed ID: 25345919
[TBL] [Abstract][Full Text] [Related]
15. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study.
Iversen L; Fielding S; Lidegaard Ø; Mørch LS; Skovlund CW; Hannaford PC
BMJ; 2018 Sep; 362():k3609. PubMed ID: 30257920
[TBL] [Abstract][Full Text] [Related]
16. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C
Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750
[TBL] [Abstract][Full Text] [Related]
17. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
[TBL] [Abstract][Full Text] [Related]
18. Contemporary Hormonal Contraception and the Risk of Breast Cancer.
Mørch LS; Skovlund CW; Hannaford PC; Iversen L; Fielding S; Lidegaard Ø
N Engl J Med; 2017 Dec; 377(23):2228-2239. PubMed ID: 29211679
[TBL] [Abstract][Full Text] [Related]
19. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases.
Vinogradova Y; Coupland C; Hippisley-Cox J
BMJ; 2020 Oct; 371():m3873. PubMed ID: 33115755
[TBL] [Abstract][Full Text] [Related]
20. Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49 years of age.
Beaber EF; Buist DS; Barlow WE; Malone KE; Reed SD; Li CI
Cancer Res; 2014 Aug; 74(15):4078-89. PubMed ID: 25085875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
